25-09-18 - Press Release

HYLOMORPH

HYLOMORPH, a multi-awarded winning Swiss medtech startup and ETHZ spin-off seed-funded by Wyss Zurich, announced it has completed a CHF 3.2m Series A financing.

read more

07-09-18 - News

Congratulations! CUTISS AG and Wingtra AG among Top 10 Swiss start-ups

Again, the TOP 100 Swiss Startup Award released who is on top of the Swiss start-up scene. Wyss Zurich funded CUTISS AG and Wingtra AG rank under the Top 10 and reached the 5th and the 7th place of the most innovative and promising Swiss start-ups. CUTISS AG grows human skin in the lab for patients that suffer from skin defects. Wingtra AG is the world's leading VTOL (vertical take off and landing) drone producer. For more information please read the articles in „startup“ on page 20 and 23 (in german).

read more

04-09-18 - Event

Wyss Zurich Entrepreneur Series „From Zero to Hero?"

Caspar Coppetti (Co-Founder, On AG) will talk about how he and his friends built On AG from product idea to a leading running shoe brand within just eight years on Tuesday, September 18, 2018 from 12.00 – 1:00 p.m. at Wyss Zurich, Weinbergstrasse 35, 8092 Zurich, E floor

read more

22-08-18 - Event

Clinical Colloquium Regenerative Medicine – August 27, 2018

Prof. Dr. med. Janine Reichenbach (Centre for Primary Immuno-deficiencies, University Children’s Hospital Zurich) will talk about "Gene Therapy – Past, Present and Future" on Monday, August 27, 2018 from 1.00 - 2.00 p.m. at Institute for Regenerative Medicine (IREM), University of Zurich, Wagistrasse 12, WAD-904 (Founders Lab), 8952 Schlieren.

read more

31-07-18 - Event

Seminar Translational and Clinical Wyss Zurich Projects

Lukas Langenegger and Dr. Carlos Mora (Wyss Zurich – ETH Zurich / University of Zurich) will talk about "Magnetic blood purification – Status quo within the Wyss Zurich hemotune project" on Tuesday, August 28, 2018 from 12:30 - 13.30 p.m. at University Hospital Zurich, Kleiner Hörsaal OST.

read more

18-07-18 - News

Sevensense – New Project at Wyss Zurich

Wyss Zurich welcomes Sevensense, a new project that develops visual navigation systems enabling service robots to navigate precisely and safely in dynamic environments.

read more

13-07-18 - Media Coverage

higgs – „Winzige Magnete im Kampf gegen Blutvergiftung“

Sepsis (blood poisoning) is fatal in every third patient. hemotune, a Wyss Zurich project, is developing a novel nanomedicine procedure that will delay disease progression and gives physicians enough time to find the right active substance. For more information, please read the article in higgs (in German).

read more

12-07-18 - Media Coverage

SRF 4 News – „US-Drohne nach England unterwegs“

For the first time in history, a 24-meter-long drone is traveling for over 30 hours from the United States to the United Kingdom. “This is representing another milestone insofar, as the large unmanned aerial vehicle is fully integrated into civil airspace”, said Roland Siegwart, Professor for Autonomous Mobile Robots at ETH Zurich and Founding Co-Director of the Wyss Zurich. Hear the radio contribution of SRF 4 News (in German).

read more

06-07-18 - Event

MINT&Pepper – Summer camps

Wyss Zurich Associate Project MINT&Pepper creates learning modules that young people can use to learn more about science, technology, engineering, and math. In their upcoming summer camp “Mission Rosetta”, the journey is going to distant comets. Between July 17-20 and July 24-27, children between 10 and 14 will have the opportunity to reprogram a robot and learn all about real space missions. For more information and registration, please

read more

01-07-18 - Media Coverage

Tages-Anzeiger – „Ein Neustart für das Immunsystem”

Stem cell transplantation in Multiple Sclerosis is a promising therapy, but was not approved in Switzerland so far. Now, the Swiss Federal Office of Public Health announced, that as of July 1, 2018, health insurers will have to cover the costs for this therapy. “Finally, this is a major breakthrough in the treatment of Multiple Sclerosis patients in Switzerland”, said Wyss Zurich Core Faculty member and University of Zurich neurologist Roland Martin, who is one of the leading MS researchers and who was the driving force behind this initiative. For more information, please read the article in Tages-Anzeiger (in German).

read more